Videos
Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Issues CRL to Anaphylm, Sublingual Film Formulation of Dibutepinephrine
2
FDA Grants Orphan Drug Designation to Zavabresib for the Treatment of Myelofibrosis
3
Expert: How Pharmacists Can Improve Access and Affordability of GLP-1 Therapies
4
Abortive Treatments for Acute Migraine: Lasmiditan and CGRP Receptor Antagonists
5